Two independent studies' 2 have reported an inverse correlation between tardive akathisia and plasma or serum iron levels in chronic psychiatric patients stabilised on neuroleptic drugs. The (p = 0-0105). There were no group differences for changes over time in medication, measures of neuroleptic induced movement disorders, apart from akathisia and clinical improvement.
Of the correlations between akathisia scores and iron and transferrin levels at both examinations, only the correlation of transferrin at follow up with akathisia scores at follow up 
Discussion
As the table shows, we were successful in recruiting an acutely treated group of psychotic patients whose neuroleptic medication increased between examinations, together with Parkinsonian side effects and akathisia scores, whereas psychiatric symptom scores decreased. Across all patients there was a small but significant decrease of transferrin levels, whereas iron levels stayed the same. This overall effect hides, however, a significant difference between groups, in that both iron and, to a larger extent, transferrin levels decreased significantly only in the akathisic patients. It appears, moreover, that patients developing akathisia during the first two weeks of admission are not characterised by initially low iron or transferrin levels. This finding is supported by the inverse correlation between akathisia scores and transferrin levels at follow up (figure), but not on admission.
Although this study is correlational and cannot lead to conclusions about causal relationships, it is tempting to explore possible mechanisms which would explain our findings. Serum transferrin concentrations are regulated in vitro in chorioid plexus epithelial 
